Beranda › Mielofibrosis › North Carolina › Durham
Uji klinis Mielofibrosis di Durham, NC
12 studi untuk Mielofibrosis mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Menerima pesertaFase 1/2
- Duke Cancer Institute, Durham
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Menerima pesertaFase 3
- Duke Blood Cancer Center, Durham
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi jauhnya
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi jauhnya
Registry of Older Patients With Cancer
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Menerima pesertaFase 1
- University of North Carolina, Chapel Hill · 10 mi jauhnya
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Menerima pesertaFase 3
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- University of North Carolina, Chapel Hill · 10 mi jauhnya
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Menerima pesertaFase 2
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauhnya
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Menerima pesertaFase 3
- Duke University Medical Center, Durham
Uji klinis Mielofibrosis di kota lain
- Houston, TX19 studi
- New York City, NY18 studi
- Boston, MA12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Miami, FL10 studi
- Salt Lake City, UT10 studi
- Atlanta, GA9 studi
- Tampa, FL9 studi
- Nashville, TN9 studi
- Cleveland, OH9 studi
- Baldwin Park, CA9 studi
Studi lain di Durham
- Kanker Payudara63 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Kanker Metastatik33 studi
- Leukemia Mieloid Akut33 studi
- Kanker Paru32 studi
- Kanker Prostat32 studi
- Kanker Kolorektal28 studi
- Leukemia Limfositik Kronis27 studi
- Kanker Ovarium27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.